Guardian Pharmacy Services, Inc.
$37.34
▲
0.98%
2026-04-21 07:10:01
guardianpharmacy.com
NYQ: GRDN
Explore Guardian Pharmacy Services, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.38 B
Current Price
$37.34
52W High / Low
$41.36 / $19.17
Stock P/E
48.3
Book Value
$3.25
Dividend Yield
—
ROCE
28.85%
ROE
26.61%
Face Value
—
EPS
$0.78
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
3,600
Beta
—
Debt / Equity
20.52
Current Ratio
1.38
Quick Ratio
1.11
Forward P/E
28.91
Price / Sales
1.74
Enterprise Value
$2.47 B
EV / EBITDA
24.07
EV / Revenue
1.71
Rating
Strong Buy
Target Price
$39.6
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 2. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 3. | Enhabit, Inc. | $13.72 | — | $702.56 M | — | 6.13% | -0.46% | $14.22 / $6.47 | $10.53 |
| 4. | Sonida Senior Living, Inc. | $34.62 | — | $1.63 B | 0.34% | -1.82% | -78% | $37.57 / $20.3 | $-0 |
| 5. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
| 6. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
| 7. | DaVita Inc. | $149.93 | 15.78 | $10.02 B | — | 14.02% | 64.85% | $159.42 / $101 | $-9.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 397.62 M | 377.43 M | 344.33 M | 329.31 M | 338.57 M | — |
| Operating Profit | 30.76 M | 16.35 M | 12.58 M | 13.01 M | 16.75 M | — |
| Net Profit | 20.92 M | 9.82 M | 9.03 M | 9.45 M | 11.94 M | — |
| EPS in Rs | 0.56 | 0.26 | 0.24 | 0.25 | 0.32 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.45 B | 1.23 B | 1.05 B | 908.91 M |
| Operating Profit | 72.7 M | -62.92 M | 40.95 M | 51.99 M |
| Net Profit | 49.22 M | -87.29 M | 23.9 M | 35.42 M |
| EPS in Rs | 1.32 | -2.34 | 0.64 | 0.95 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 412.66 M | 320.81 M | 271.17 M | 256.11 M |
| Total Liabilities | 194.73 M | 170.83 M | 211.31 M | 180.19 M |
| Equity | 205.76 M | 142.67 M | 0 M | 0 M |
| Current Assets | 221.63 M | 151.99 M | 129.6 M | 120 M |
| Current Liabilities | 160.7 M | 144.12 M | 138.01 M | 112 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 100.25 M | 57.96 M | 70.82 M | 48.52 M |
| Investing CF | -32.23 M | -30.41 M | -13.44 M | -17.9 M |
| Financing CF | -7.07 M | -23.64 M | -57.23 M | -45.03 M |
| Free CF | 80.71 M | 41.59 M | 56.26 M | 31.75 M |
| Capex | -19.55 M | -16.37 M | -14.56 M | -16.77 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 17.42% | 15.1% | — | — |
| Earnings Growth % | -465.19% | -32.52% | — | — |
| Profit Margin % | -7.11% | 2.28% | 3.9% | — |
| Operating Margin % | -5.12% | 3.91% | 5.72% | — |
| Gross Margin % | 19.89% | 19.91% | 20.45% | — |
| EBITDA Margin % | -3.54% | 5.62% | 7.5% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.